IXING Biotechnology
Investors Count
5Funding, Valuation & Revenue
5 Fundings
IXING Biotechnology's latest funding round was a Series B for on April 21, 2020.
Date | Round | Amount | Investors | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Revenue | Sources |
---|---|---|---|---|---|---|
4/21/2020 | Series B | 4 | ||||
6/8/2018 | Series A - II | |||||
4/12/2017 | Series A | |||||
8/5/2016 | Seed | |||||
Other Investors |
Date | 4/21/2020 | 6/8/2018 | 4/12/2017 | 8/5/2016 | |
---|---|---|---|---|---|
Round | Series B | Series A - II | Series A | Seed | Other Investors |
Amount | |||||
Investors | |||||
Valuation | |||||
Revenue | |||||
Sources | 4 |
This profile has not been claimed.
You're more than your latest funding, tell our customers your company's story.
IXING Biotechnology Investors
5 Investors
IXING Biotechnology has 5 investors. Yushan Partners invested in IXING Biotechnology's Series B funding round.
First funding | Last Funding | Investor | Rounds | Board Seats | Type | Location |
---|---|---|---|---|---|---|
4/21/2020 | 4/21/2020 | 1 Series B | Asset/Investment Management | |||
Private Equity | China | |||||
Venture Capital | China | |||||
Corporation | China | |||||
Corporation | China |
First funding | 4/21/2020 | ||||
---|---|---|---|---|---|
Last Funding | 4/21/2020 | ||||
Investor | |||||
Rounds | 1 Series B | ||||
Board Seats | |||||
Type | Asset/Investment Management | Private Equity | Venture Capital | Corporation | Corporation |
Location | China | China | China | China |
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.